AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
-13.31%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| 1 |
Merck
MRK
|
+$366M |
| 2 |
Verizon
VZ
|
+$305M |
| 3 |
HCA Healthcare
HCA
|
+$237M |
| 4 |
Comcast
CMCSA
|
+$216M |
| 5 |
United Airlines
UAL
|
+$213M |
Top Sells
| 1 |
Intel
INTC
|
+$362M |
| 2 |
Texas Instruments
TXN
|
+$326M |
| 3 |
LyondellBasell Industries
LYB
|
+$277M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$262M |
| 5 |
Northrop Grumman
NOC
|
+$250M |
Sector Composition
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.15% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Red Rock Resorts
RRR
$3.65B
| $264K | ﹤0.01% |
13,001
-27,947
| -68% | -$567K |
|
2002
Novavax
NVAX
$1.3B
| $263K | ﹤0.01% |
7,157
+1,969
| +38% | +$72.4K |
|
2003
Axcelis
ACLS
$2.69B
| $262K | ﹤0.01% |
14,735
-55,917
| -79% | -$994K |
|
2004
Viking Therapeutics
VKTX
$2.79B
| $261K | ﹤0.01% |
34,156
-26,778
| -44% | -$205K |
|
|
XOG
2005
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $261K | ﹤0.01% |
+60,770
| New | +$261K |
|
|
CALA
2006
DELISTED
Calithera Biosciences, Inc
CALA
| $260K | ﹤0.01% |
3,243
-523
| -14% | -$41.9K |
|
2007
Astronics
ATRO
$1.41B
| $259K | ﹤0.01% |
+8,503
| New | +$259K |
|
2008
Helix Energy Solutions
HLX
$914M
| $259K | ﹤0.01% |
47,933
-52,278
| -52% | -$282K |
|
|
GHL
2009
DELISTED
Greenhill & Co., Inc.
GHL
| $259K | ﹤0.01% |
+10,599
| New | +$259K |
|
|
MFA
2010
MFA Financial
MFA
$1.04B
| $257K | ﹤0.01% |
9,613
-12,731
| -57% | -$340K |
|
2011
National Storage Affiliates Trust
NSA
$2.45B
| $257K | ﹤0.01% |
9,723
-376
| -4% | -$9.94K |
|
|
ACH
2012
DELISTED
Alum Corp of China Limited
ACH
| $257K | ﹤0.01% |
32,835
+2,757
| +9% | +$21.6K |
|
|
BOLD
2013
DELISTED
Audentes Therapeutics, Inc
BOLD
| $257K | ﹤0.01% |
12,046
-13,637
| -53% | -$291K |
|
|
ALDR
2014
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $257K | ﹤0.01% |
25,097
+4,304
| +21% | +$44.1K |
|
2015
Horizon Bancorp
HBNC
$833M
| $255K | ﹤0.01% |
16,145
-24,421
| -60% | -$386K |
|
2016
TruBridge
TBRG
$302M
| $255K | ﹤0.01% |
+10,160
| New | +$255K |
|
2017
Tyler Technologies
TYL
$23.6B
| $254K | ﹤0.01% |
1,368
+160
| +13% | +$29.7K |
|
2018
American Coastal Insurance
ACIC
$538M
| $252K | ﹤0.01% |
15,144
+3,803
| +34% | +$63.3K |
|
2019
Badger Meter
BMI
$5.24B
| $252K | ﹤0.01% |
5,118
-2,836
| -36% | -$140K |
|
2020
Ardelyx
ARDX
$1.59B
| $251K | ﹤0.01% |
140,030
+52,633
| +60% | +$94.3K |
|
|
GWR
2021
DELISTED
Genesee & Wyoming Inc.
GWR
| $251K | ﹤0.01% |
+3,397
| New | +$251K |
|
|
ASXC
2022
DELISTED
Asensus Surgical, Inc.
ASXC
| $250K | ﹤0.01% |
8,520
-4,725
| -36% | -$139K |
|
2023
Agios Pharmaceuticals
AGIO
$2.14B
| $249K | ﹤0.01% |
5,392
-7,017
| -57% | -$324K |
|
|
HOME
2024
DELISTED
At Home Group Inc.
HOME
| $249K | ﹤0.01% |
13,344
-13,668
| -51% | -$255K |
|
|
BMS
2025
DELISTED
Bemis
BMS
| $247K | ﹤0.01% |
5,383
-11,899
| -69% | -$546K |
|